News Merck & Co pulls Keytruda lung cancer filing in Europe Blow for Merck as Keytruda sales top $1 billion per quarter.
News Novartis adds to cancer reach with $3.9 billion acquisition Novartis backs ambition to be oncology world-leader
Events Partner Content Immuno-Oncology 360° Summit Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including:
News NICE rejects Bayer and Eisai drugs in thyroid cancer Thyroid cancer drugs are available in Scotland and Wales
News After surging on lung cancer data, Ignyta looks to raise $16... San Diego based biotech firm Ignyta is capping off a week of success with a public stock offering t
News Roche MS drug sales rise, but so does biosimilar threat Ocrevus shines as biosimilars bite in Europe
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
